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THE AUTHORS REPLY
We read with interest the letter fromMeyre (1) about our re-
cently published systematic review andmeta-analysis on the as-
sociations of variants of the proprotein convertase subtilisine/
kexin type 1 gene (PCSK1) with obesity (2). In his letter,Meyre
outlines in 4 criticisms what he perceives to be weaknesses or
errors in our paper. We address these criticisms below.
According to Meyre, our meta-analysis included 2 over-
lapping cohorts (3, 4). Had this been the case, it clearly
would have affected the interpretation of our results. How-
ever, contrary to his assertion and as Table 1 shows, no over-
lapping data were included in our meta-analysis. This is also
evident fromTables 2 and 3 in our original article (2). The key
argument of the letter is therefore incorrect.
In his second point, Meyre suggested that our analysis was
underpowered to find a significant association of rs6232 with
body mass index (BMI) and waist circumference. Statistical
power calculations are planning tools used to estimate the
probability of detecting an association between variables
within their data set before the analyses are conducted.
Once an association is determined, probabilistic assumptions
about the presence or absence of an association within the
data set are redundant (5–7). It is generally agreed that focus-
ing on post-hoc power and/or the probability statistics (P val-
ues) could bias the interpretation of data and diminish the
value of such analyses (5, 6, 8–12). Nevertheless, we agree
with Meyre that it is worth considering whether results that
were not statistically significant in our meta-analysis might
turn out to be so in future analyses that include larger sample
sizes. We addressed this issue on page 1062 of our article.
Nevertheless, it is important to keep in mind the clearly stated
purpose of our study, which was to report the results of a sys-
tematic review and meta-analysis of relevant data published
before December 2013. Thus, because our meta-analysis
was, to our knowledge, fully inclusive of studies published
up to this date, speculating about how the inclusion of addi-
tional materials that do not exist within this timeframe is of
questionable merit.
The third point raised byMeyre was that we misinterpreted
the literature on PCSK1 variants and obesity. He specifically
focused on a section of the Introduction in which we stated
that specificPCSK1 single nucleotide polymorphisms (SNPs)
were only marginally associated with BMI in published stud-
ies. Meyre implied that we disregarded the established stron-
ger associations of other SNPs that are proximal to PCSK1
with BMI. However, in our Introduction, we referred to the
literature on SNPs rs6232 and rs6234–rs6235, as these were
the focus of our meta-analysis. Meyre appears to have over-
looked the section of the Discussion in which we highlighted
that 2 other SNPs proximal to PCSK1 have stronger associa-
tions with BMI and waist circumference (13, 14).
Finally, Meyre suggested that when we discussed the asso-
ciation of the rs6232 variant with childhood obesity versus
adulthood obesity, we overlooked 2 key studies. However,
the first of these studies (15), in which analyses compared
Table 1. Comparison of Included Cohorts and Potentially Overlapping Cohorts
First Author, Year
(Reference No.) Cohort Description
No. of
Cases
No. of
Controls
Cohorts Included in Our Meta-Analysis (No Overlap)
Benzinou, 2008 (4) Cases recruited by Centre National de la Recherche Scientifique
Unités Mixtes de Recherché 8090 and Hôtel-Dieu de Paris;
3 separate control cohorts
1,045 1,265
Meyre, 2009 (3) French adults: obese patients from Centre Hospitalier Régional
Universitaire de Lille and controls from the Supplémentation en
Vitamines et Minéraux Anti-Oxydants Study
135 795
Cohorts Incorrectly Asserted to Have Been Included in Our Meta-Analyses (Overlap)
Benzinou, 2008 (4) Cases recruited by Centre National de la Recherche Scientifique
Unités Mixtes de Recherché 8090 and Hôtel-Dieu de Paris;
3 separate control cohorts
1,045 1,265
Meyre, 2009 (3) Cases recruited by CNRS Unités Mixtes de Recherché 8090 and
Hôtel-Dieu de Paris
695 731
Letters to the Editor 733
Am J Epidemiol. 2015;181(9):732–735
 at K
U
 Leuven U
niversity Library on A
ugust 4, 2015
http://aje.oxfordjournals.org/
D
ow
nloaded from
 
adults whowere younger than 59 years with thosewhowere 59
years of age or older (and therefore were not focused on child-
hood obesity), is clearly referred to in the Results section of our
paper. The paper by Choquet et al. (16), which was also fo-
cused on adults, was not cited within this context. Although
each of these studies reported meritorious findings, extrapolat-
ing findings on the genetics of adult obesity to the pediatric set-
ting would be unwise in our view because of the differences in
physiology between these groups. Thus, the novel finding of
our study to which Meyre refers is fully substantiated by the
evidence, and our decision not to draw strong parallels to stud-
ies in adults is fully defensible in our view.
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RE: “COFFEE CONSUMPTION AND MORTALITY FROM ALL CAUSES, CARDIOVASCULAR DISEASE, AND
CANCER: A DOSE-RESPONSE META-ANALYSIS”
In their recent meta-analysis, Crippa et al. (1) reported that
coffee consumption is inversely associated with all-cause and
cardiovascular disease mortality. The largest risk reduction
(21%, 95% confidence interval: 16, 26) was observed for car-
diovascular disease mortality at a level of 3 cups/day (1). This
remarkable finding should encourage many people to continue,
or even increase, their coffee consumption. For once, it will be
fairly easy to comply with advice on adopting a healthier diet.
Coffee consumption has been reported to have a hypercho-
lesterolemic effect, leading to adverse cardiovascular out-
comes (2). Cafestol and kahweol occur naturally in coffee
beans and have been identified as hypercholesterolemic com-
pounds (3). The associations of coffee with serum lipoprotein
concentrations are largelydependent on themethodof its prep-
aration. For example, cafestol and kahweol are not present
in regular coffee made with drip coffee-makers, as they are
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